Pages that link to "Q28475032"
The following pages link to S9, a novel anticancer agent, exerts its anti-proliferative activity by interfering with both PI3K-Akt-mTOR signaling and microtubule cytoskeleton (Q28475032):
Displaying 27 items.
- Bicyclic triterpenoid Iripallidal induces apoptosis and inhibits Akt/mTOR pathway in glioma cells (Q21261315) (← links)
- Small molecule R1498 as a well-tolerated and orally active kinase inhibitor for hepatocellular carcinoma and gastric cancer treatment via targeting angiogenesis and mitosis pathways (Q27317155) (← links)
- Sustained proliferation in cancer: Mechanisms and novel therapeutic targets (Q28396388) (← links)
- Image-based compound profiling reveals a dual inhibitor of tyrosine kinase and microtubule polymerization (Q28834113) (← links)
- A novel sulfonamide agent, MPSP-001, exhibits potent activity against human cancer cells in vitro through disruption of microtubule (Q33567298) (← links)
- Synthesis of phenstatin/isocombretastatin-chalcone conjugates as potent tubulin polymerization inhibitors and mitochondrial apoptotic inducers (Q35568576) (← links)
- Synthesis of 2-anilinopyridyl-triazole conjugates as antimitotic agents (Q35576061) (← links)
- Chamaejasmin B exerts anti-MDR effect in vitro and in vivo via initiating mitochondria-dependant intrinsic apoptosis pathway (Q36111203) (← links)
- Potential impact of mTOR inhibitors on cervical squamous cell carcinoma: A systematic review (Q36206239) (← links)
- An overview of tubulin inhibitors that interact with the colchicine binding site (Q36885540) (← links)
- Ultrapotent vinblastines in which added molecular complexity further disrupts the target tubulin dimer-dimer interface (Q37258490) (← links)
- Targeted regulation of PI3K/Akt/mTOR/NF-κB signaling by indole compounds and their derivatives: mechanistic details and biological implications for cancer therapy (Q37512204) (← links)
- Synergistic combination of novel tubulin inhibitor ABI-274 and vemurafenib overcome vemurafenib acquired resistance in BRAFV600E melanoma. (Q37625891) (← links)
- Discovery and Optimization of Novel 5-Indolyl-7-arylimidazo[1,2-a]pyridine-8-carbonitrile Derivatives as Potent Antitubulin Agents Targeting Colchicine-binding Site (Q37668082) (← links)
- New microtubule-inhibiting anticancer agents (Q37689138) (← links)
- Progress in the design and development of phosphoinositide 3-kinase (PI3K) inhibitors for the treatment of chronic diseases (Q37872280) (← links)
- Novel quinolone chalcones targeting colchicine-binding pocket kill multidrug-resistant cancer cells by inhibiting tubulin activity and MRP1 function (Q38599086) (← links)
- EGFR inhibitor BIBU induces apoptosis and defective autophagy in glioma cells (Q39321309) (← links)
- Discovery of novel 2-N-aryl-substituted benzenesulfonamidoacetamides: orally bioavailable tubulin polymerization inhibitors with marked antitumor activities (Q39400503) (← links)
- Centchroman inhibits proliferation of head and neck cancer cells through the modulation of PI3K/mTOR Pathway (Q39629297) (← links)
- Imidazoquinoxaline anticancer derivatives and imiquimod interact with tubulin: Characterization of molecular microtubule inhibiting mechanisms in correlation with cytotoxicity. (Q41349651) (← links)
- Design, synthesis and structure-activity relationship of 3,6-diaryl-7H-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazines as novel tubulin inhibitors. (Q41696987) (← links)
- Synthesis of a Potent Vinblastine: Rationally Designed Added Benign Complexity (Q42108336) (← links)
- An improved Akt reporter reveals intra- and inter-cellular heterogeneity and oscillations in signal transduction. (Q42799486) (← links)
- Microtubule Depolymerization by Kinase Inhibitors: Unexpected Findings of Dual Inhibitors. (Q48246859) (← links)
- HSP90 inhibitor AUY922 abrogates up-regulation of RTKs by mTOR inhibitor AZD8055 and potentiates its antiproliferative activity in human breast cancer. (Q53059131) (← links)
- [Advances of aberrant signaling pathways and related targeting drugs in B cell non- Hodgkin lymphoma] (Q87063062) (← links)